HLS Therapeutics, Inc. (HLS.TO)
3.71
+0.01
(+0.27%)
CAD |
TSX |
Nov 13, 16:00
HLS Therapeutics Market Cap : 116.01M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 116.01M |
| November 12, 2026 | 115.70M |
| November 11, 2026 | 131.02M |
| November 10, 2026 | 129.77M |
| November 09, 2026 | 136.65M |
| November 06, 2026 | 137.90M |
| November 05, 2026 | 138.84M |
| November 04, 2026 | 132.90M |
| November 03, 2026 | 132.27M |
| November 02, 2026 | 139.77M |
| October 30, 2026 | 141.02M |
| October 29, 2026 | 142.59M |
| October 28, 2026 | 142.59M |
| October 27, 2026 | 142.90M |
| October 26, 2026 | 139.46M |
| October 23, 2026 | 135.40M |
| October 22, 2026 | 129.77M |
| October 21, 2026 | 129.14M |
| October 20, 2026 | 129.77M |
| October 19, 2026 | 127.89M |
| October 16, 2026 | 128.20M |
| October 15, 2026 | 129.46M |
| October 14, 2026 | 128.20M |
| October 13, 2026 | 126.64M |
| October 09, 2026 | 127.89M |
| Date | Value |
|---|---|
| October 08, 2026 | 131.33M |
| October 07, 2026 | 132.90M |
| October 06, 2026 | 131.33M |
| October 05, 2026 | 131.64M |
| October 02, 2026 | 121.01M |
| October 01, 2026 | 121.64M |
| September 30, 2026 | 131.33M |
| September 29, 2026 | 124.76M |
| September 28, 2026 | 125.08M |
| September 25, 2026 | 125.70M |
| September 24, 2026 | 123.20M |
| September 23, 2026 | 123.51M |
| September 22, 2026 | 123.83M |
| September 21, 2026 | 124.14M |
| September 18, 2026 | 122.26M |
| September 17, 2026 | 124.76M |
| September 16, 2026 | 126.02M |
| September 15, 2026 | 127.89M |
| September 14, 2026 | 129.77M |
| September 11, 2026 | 121.95M |
| September 10, 2026 | 116.63M |
| September 09, 2026 | 117.26M |
| September 08, 2026 | 118.20M |
| September 04, 2026 | 115.70M |
| September 03, 2026 | 112.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bausch Health Cos., Inc. | 4.457B |
| Cipher Pharmaceuticals, Inc. | 360.13M |
| BioSyent, Inc. | 201.74M |
| Revive Therapeutics Ltd. | 6.535M |
| Knight Therapeutics, Inc. | 1.185B |
Market Cap Related Metrics
| PS Ratio | 1.465 |
| Price to Book Value | 1.551 |
| Price to Free Cash Flow | 5.010 |
| Price | 3.71 |
| Earnings Yield | -8.26% |